Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Luminex (LMNX)

Add to Watchlists
Create an Alert
17.32 -0.32  -1.81% NASDAQ Apr 23, 8:00PM BATS Real time Currency in USD
View Full Chart
LMNX Price Chart
View All Events

LMNX Events

Date Type Description
Apr 28 Misc Luminex Corporation Q1 2014 Earning Conference Call
Apr 28 Earnings Luminex Corporation Q1 2014 Earning Result. Estimate: 0.11.
Feb 03 Misc Q4 2013 Luminex Corp Earnings Conference Call
Feb 03 Earnings Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014. Estimate: 0.08.
Nov 04 Earnings Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2013. Estimate: 0.12.
Nov 04 Misc Q3 2013 Luminex Corp Earnings Conference Call
Jul 29 Misc Luminex Corporation Second Quarter Earnings Conference Call
Jul 29 Earnings Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013. Estimate: 0.09.
May 16 Misc AGM Event for Luminex Corp
Apr 29 Misc Q1 2013 Luminex Corp Earnings Conference Call
View All Performance Charts

LMNX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Luminex is up 4.65% over the last year vs S&P 500 Total Return up 21.33%, AngioDynamics up 41.03%, and Affymetrix up 116.8%.

Get Quote for

PDF Report for LMNX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download LMNX Pro Report PDF

Portfolio Strategies Featuring LMNX

Did Luminex make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

LMNX Profile

  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Headquarters Country: United States
  • Headquarters State/Province: Texas
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Industry Code: 5417
  • NAICS Sector: Professional, Scientific, and Technical Services
  • NAICS Sector Code: 54

Luminex Corporation is a biotechnology company based in Austin, Texas, with offices in Australia, Toronto and the Netherlands. Luminex develops, manufactures and markets proprietary biological testing technologies with applications throughout the life-sciences industry. The company operates its business through two segments: Technology and Strategic Partnerships (TSP) and Assays and Related Products (ARP). Patrick J. Balthrop, Sr. has served as Luminex's President and Chief Executive Officer since May, 2004. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. Luminex was recently recognized by Forbes magazine as one of the top 25 fastest growing technology companies in the US. The company was founded in 1995.

Recent Quotes

Symbol Price Chg Chg % Market Cap
LMNX 17.32 -0.32 -1.81% 712.44M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.